First International Consensus on the diagnosis and management of fibromuscular dysplasia.

Angiography / standards Angioplasty / adverse effects Cardiovascular Agents / adverse effects Clinical Decision-Making Consensus Fibromuscular Dysplasia / diagnostic imaging Genetic Predisposition to Disease Humans Predictive Value of Tests Risk Factors Treatment Outcome
aneurysm cervical artery dissection fibromuscular dysplasia (FMD) percutaneous angioplasty pressure gradients renovascular hypertension spontaneous coronary artery dissection

Journal

Vascular medicine (London, England)
ISSN: 1477-0377
Titre abrégé: Vasc Med
Pays: England
ID NLM: 9610930

Informations de publication

Date de publication:
04 2019
Historique:
pubmed: 17 1 2019
medline: 29 5 2019
entrez: 17 1 2019
Statut: ppublish

Résumé

This article is a comprehensive document on the diagnosis and management of fibromuscular dysplasia (FMD), which was commissioned by the working group 'Hypertension and the Kidney' of the European Society of Hypertension (ESH) and the Society for Vascular Medicine (SVM). This document updates previous consensus documents/scientific statements on FMD published in 2014 with full harmonization of the position of European and US experts. In addition to practical consensus-based clinical recommendations, including a consensus protocol for catheter-based angiography and percutaneous angioplasty for renal FMD, the document also includes the first analysis of the European/International FMD Registry and provides updated data from the US Registry for FMD. Finally, it provides insights on ongoing research programs and proposes future research directions for understanding this multifaceted arterial disease.

Identifiants

DOI: 10.1177/1358863X18821816 PMID: 30648921
pubmed: 30648921
doi: 10.1177/1358863X18821816
doi:

Substances chimiques

Cardiovascular Agents 0

Types de publication

Journal Article Practice Guideline Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

164-189

Subventions

Organisme : British Heart Foundation
ID : PG/13/96/30608
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn
Type : ErratumIn

Auteurs

Heather L Gornik (HL)

1 Division of Cardiovascular Medicine, University Hospitals Cleveland Medical Center and UH Harrington Heart and Vascular Institute, Cleveland, OH, USA.

Alexandre Persu (A)

2 Division of Cardiology, Department of Cardiovascular Diseases, Cliniques Universitaires Saint-Luc and Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.

David Adlam (D)

3 Department of Cardiovascular Sciences, Glenfield Hospital, Leicester, UK.
4 NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.

Lucas S Aparicio (LS)

5 Hypertension Section, Internal Medicine Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Michel Azizi (M)

6 Paris Descartes University, Paris, France.
7 Assistance-Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Hypertension Unit, Paris, France.
8 Institut national de la santé et de la recherche médicale, Centre d'Investigation Clinique 1418, Paris, France.

Marion Boulanger (M)

9 Normandie Université, UNICAEN, Inserm U1237, CHU Caen Normandie, Caen, France.

Rosa Maria Bruno (RM)

10 Department of Clinical and Experimental Medicine University of Pisa, Pisa, Italy.

Peter de Leeuw (P)

11 Department of Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.

Natalia Fendrikova-Mahlay (N)

12 Department of Cardiovascular Medicine, Cleveland Clinic Heart and Vascular Institute, Cleveland, OH, USA.

James Froehlich (J)

13 Department of Internal Medicine, Frankel Cardiovascular Center, University of Michigan, Ann Arbor, MI, USA.

Santhi K Ganesh (SK)

13 Department of Internal Medicine, Frankel Cardiovascular Center, University of Michigan, Ann Arbor, MI, USA.

Bruce H Gray (BH)

14 University of South Carolina School of Medicine/Greenville, Greenville, SC, USA.

Cathlin Jamison (C)

15 Association belge de patients atteints de Dysplasie Fibromusculaire/FMD Groep België (FMD-Be), Brussels, Belgium.

Andrzej Januszewicz (A)

16 Department of Hypertension, Institute of Cardiology, Warsaw, Poland.

Xavier Jeunemaitre (X)

17 APHP, Department of Genetics and Centre for Rare Vascular Diseases, Hôpital Européen Georges Pompidou, Paris, France.
18 INSERM, U970 - PARCC, University Paris Descartes, Sorbonne Paris Cité, Paris, France.

Daniella Kadian-Dodov (D)

19 Zena and Michael A Wiener Cardiovascular Institute and Marie-Josée and Henry R. Kravis Center for Cardiovascular Health; Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Esther Sh Kim (ES)

20 Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Jason C Kovacic (JC)

19 Zena and Michael A Wiener Cardiovascular Institute and Marie-Josée and Henry R. Kravis Center for Cardiovascular Health; Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Pamela Mace (P)

21 Fibromuscular Dysplasia Society of America (FMDSA), North Olmsted, OH, USA.

Alberto Morganti (A)

22 Centro Fisiologia Clinica e Ipertensione, Policlinico Hospital, University of Milan, Milan, Italy.

Aditya Sharma (A)

23 Department of Medicine, Cardiovascular Medicine Division, University of Virginia, Charlottesville, VA, USA.

Andrew M Southerland (AM)

24 Department of Neurology, University of Virginia, Charlottesville, VA, USA.

Emmanuel Touzé (E)

9 Normandie Université, UNICAEN, Inserm U1237, CHU Caen Normandie, Caen, France.

Patricia van der Niepen (P)

25 Department of Nephrology & Hypertension Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.

Jiguang Wang (J)

26 Shanghai Institute of Hypertension and Center for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Ido Weinberg (I)

27 Vascular Medicine Section and Vascular Center, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.

Scott Wilson (S)

28 Monash University (Central Clinical School of Medicine), Melbourne, VIC, Australia.
29 Department of Renal Medicine, Alfred Health, Melbourne, VIC, Australia.

Jeffrey W Olin (JW)

19 Zena and Michael A Wiener Cardiovascular Institute and Marie-Josée and Henry R. Kravis Center for Cardiovascular Health; Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Pierre-Francois Plouin (PF)

6 Paris Descartes University, Paris, France.
7 Assistance-Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Hypertension Unit, Paris, France.
8 Institut national de la santé et de la recherche médicale, Centre d'Investigation Clinique 1418, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic cardiovasculaire › Angiographie › First International Consensus on the diagnosis...
questionsmedicales.fr › Techniques d'investigation › Cathétérisme › Angioplastie › First International Consensus on the diagnosis...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents cardiovasculaires › First International Consensus on the diagnosis...
questionsmedicales.fr › Diagnostic › Prise de décision clinique › First International Consensus on the diagnosis...
questionsmedicales.fr › Phénomènes psychologiques › Processus mentaux › Pensée (activité mentale) › Prise de décision › Consensus › First International Consensus on the diagnosis...
questionsmedicales.fr › Maladies cardiovasculaires › Maladies vasculaires › Artériopathies oblitérantes › Dysplasie fibromusculaire › First International Consensus on the diagnosis...
questionsmedicales.fr › Phénomènes génétiques › Génotype › Prédisposition génétique à une maladie › First International Consensus on the diagnosis...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › First International Consensus on the diagnosis...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Méthodologie en recherche épidémiologique › Valeur prédictive des tests › First International Consensus on the diagnosis...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › First International Consensus on the diagnosis...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation des résultats et des processus en soins de santé › Évaluation de résultat (soins) › Résultat thérapeutique › First International Consensus on the diagnosis...